Glycomet-GP 3 Forte (Metformin/Glimepiride)

Price range: 74.00$ through 202.00$

Product Overview Glycomet-GP 3 Forte is a prescription oral antidiabetic medication formulated for the management of type 2 diabetes mellitus. Manufactured by USV Pvt Ltd, each strip contains ten sustained-release tablets that combine metformin and g

Pack Size	Price	Quantity
60 Tablet/s	74.00$
120 Tablet/s	117.00$
240 Tablet/s	202.00$

Estimated Delivery: Mon, Jun 22 – Wed, Jun 24

... people are viewing this right now

Guaranteed Safe Checkout

🔒 We Accept — Secure International Payment

Bank Transfer

Wire / SWIFT

Zelle

US bank transfer

Crypto

BTC / ETH / USDT

Venmo

US payment app

After placing your order, you will receive full payment details by email. Your order is dispatched within 24 hours of payment confirmation. You can also order directly via WhatsApp for the fastest service.

🚚 Worldwide Shipping — Fully Tracked & Insured

United States

Standard tracked delivery

7–14 Business Days

United Kingdom

Standard tracked delivery

5–10 Business Days

Australia

Standard tracked delivery

10–18 Business Days

Rest of World

50+ countries available

10–20 Business Days

All orders are shipped in plain, discreet packaging with no pharmacy or medicine reference outside. Tracking number is sent by email after dispatch. Shipped from Mumbai, India.

Description

Product Overview

Glycomet-GP 3 Forte is a prescription oral antidiabetic medication formulated for the management of type 2 diabetes mellitus. Manufactured by USV Pvt Ltd, each strip contains ten sustained-release tablets that combine metformin and glimepiride in a fixed 1000 mg/3 mg strength. The product is packaged in blister packs of 10 tablets and is available in three pack sizes—60, 120, and 240 tablets—to suit individual treatment plans. This combination therapy addresses both insulin resistance and sulfonylurea-mediated glucose stimulation, offering a convenient single-tablet regimen for patients seeking improved glycemic control.

What is Glycomet-GP 3 Forte

The active ingredients in Glycomet-GP 3 Forte are metformin, a biguanide that decreases hepatic glucose production, and glimepiride, a sulfonylurea that enhances insulin release from pancreatic β-cells. Metformin works by activating AMP-activated protein kinase, leading to reduced gluconeogenesis and improved peripheral insulin sensitivity. Glimepiride binds to the Kir6.2 subunit of ATP-sensitive potassium channels on β-cells, triggering depolarization and insulin secretion. Together, these mechanisms lower fasting and post-prandial glucose levels, supporting the broader therapeutic goals outlined by the American Diabetes Association.

Uses and Benefits

Clinically, Glycomet-GP 3 Forte is indicated for adults with type 2 diabetes who have not achieved adequate control with diet and exercise alone. The dual-action formulation helps achieve target HbA1c reductions of up to 1.5% when used as monotherapy or in combination with other oral agents. Patients experience weight neutrality or weight loss, a benefit valuable in a population where weight gain is a common side effect of many diabetes therapies. Additionally, the sustained-release matrix minimizes peak plasma concentrations, reducing gastrointestinal discomfort and supporting better adherence to prescribed regimens.

How It Works

The recommended dosing schedule for Glycomet-GP 3 Forte is to take one tablet with the first main meal of the day, typically breakfast. This timing aligns the absorption of metformin with peak post-prandial glucose rise, enhancing its glucose-lowering effect while minimizing gastrointestinal upset. Taking the tablet with food also reduces the likelihood of stomach irritation. Patients should avoid taking the medication on an empty stomach, as this can increase the risk of nausea and may alter the drug’s plasma levels. Consistency in timing helps maintain steady therapeutic concentrations.

Dosage Guidelines

The recommended starting dose of Glycomet-GP 3 Forte is one tablet taken with the morning meal, providing 1000 mg of metformin and 3 mg of glimepiride. A healthcare provider may increase the metformin component up to 2000 mg per day, divided into two doses, while limiting glimepiride to a maximum of 6 mg daily. Patients should swallow the tablet whole, avoid crushing, and maintain regular meal timing to optimize absorption. Routine monitoring of renal function and blood glucose is essential to adjust therapy safely.

Side Effects

Like all antidiabetic agents, Glycomet-GP 3 Forte can be associated with adverse effects, the most commonly reported being gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. These events are usually mild and transient, often resolving with continued use or dose modification. Less frequent but clinically important side effects include hypoglycemia, particularly when combined with other insulin secretagogues or insulin therapy, and rare cases of lactic acidosis, which requires immediate medical attention. For more information, see the National Institutes of Health. Patients should be advised to report persistent gastrointestinal symptoms, signs of low blood sugar, or unexplained fatigue to their physician.

Warnings and Precautions

Glycomet-GP 3 Forte is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, or known hypersensitivity to metformin or glimepiride. Prior to initiation, clinicians should assess hepatic function, cardiac status, and history of pancreatitis, as these conditions may increase the risk of lactic acidosis or other complications. The medication should be temporarily discontinued before any surgical procedures requiring contrast dye, and patients are urged to maintain adequate hydration to support renal clearance. Pregnant or lactating women should avoid its use unless specifically directed by a qualified obstetric or endocrinology specialist.

Additional Information

Understanding how to use Glycomet-GP 3 Forte safely and effectively empowers patients to achieve optimal diabetes management. The following frequently asked questions address common concerns regarding its use, storage, and interaction potential.

FAQs

Q: What is the best time of day to take Glycomet-GP 3 Forte? A: The recommended dosing schedule for Glycomet-GP 3 Forte is to take one tablet with the first main meal of the day, typically breakfast. This timing aligns the absorption of metformin with peak post-prandial glucose rise, enhancing its glucose-lowering effect while minimizing gastrointestinal upset. Taking the tablet with food also reduces the likelihood of stomach irritation. Patients should avoid taking the medication on an empty stomach, as this can increase the risk of nausea and may alter the drug’s plasma levels. Consistency in timing helps maintain steady therapeutic concentrations.
Q: Can Glycomet-GP 3 Forte be taken with other diabetes medications? A: It is generally safe to combine Glycomet-GP 3 Forte with certain oral antidiabetic agents such as DPP-4 inhibitors or SGLT-2 inhibitors, provided the total daily dose of sulfonylurea remains within the approved limit. However, co-administration with other insulin secretagogues, including sulfonylureas other than glimepiride, or with insulin therapy, can potentiate hypoglycemic episodes, requiring close glucose monitoring and possible dose reduction. Patients should always consult their healthcare provider before adding or changing any concomitant medication to ensure safety and efficacy.
Q: How should the tablets be stored? A: Glycomet-GP 3 Forte tablets should be stored at room temperature, away from direct heat, moisture, and excessive sunlight. The blister packs are designed to protect the medication from environmental factors that could compromise tablet integrity. Keep the medication out of reach of children and pets, and do not transfer tablets to another container unless instructed by a pharmacist. If the product shows signs of discoloration, crumbling, or an unusual odor, it should be discarded and a new supply obtained. Proper storage preserves the sustained-release coating and ensures consistent dosing throughout the treatment course.
Q: Is weight loss expected while on this medication? A: Weight changes are a common concern for individuals managing type 2 diabetes, and Glycomet-GP 3 Forte is generally considered weight-neutral. Unlike some sulfonylureas that can promote weight gain, the metformin component tends to reduce appetite and may support weight maintenance or slight loss in some patients. However, individual responses vary based on diet, physical activity, and baseline metabolism. Patients who notice significant weight fluctuations should discuss these observations with their clinician, who can evaluate whether adjustments to nutrition, exercise, or medication dosage are warranted to align with their overall health goals.
Q: What should I do if I miss a dose? A: If a dose of Glycomet-GP 3 Forte is missed, the patient should take the tablet as soon as remembered, provided there is sufficient time before the next scheduled dose. However, if it is nearly time for the next dose, the missed tablet should be skipped and the regular dosing schedule resumed; double dosing should be avoided to prevent excessive medication levels. Patients are advised to keep a medication diary to track intake and to set reminders, such as alarm cues or pill organizers, to reduce the frequency of missed doses. Consistent adherence helps maintain stable glycemic control and reduces hyperglycemia risk.